Market capitalization | €324.81m |
Enterprise Value | €320.81m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 21.53 |
EV/Sales (TTM) EV/Sales | 0.35 |
P/S ratio (TTM) P/S ratio | 0.35 |
P/B ratio (TTM) P/B ratio | 0.33 |
Revenue growth (TTM) Revenue growth | -9.79% |
Revenue (TTM) Revenue | €919.20m |
As a Free StocksGuide user, you can view scores for all 6,840 stocks worldwide.
5 Analysts have issued a Euroapi forecast:
5 Analysts have issued a Euroapi forecast:
Dec '24 |
+/-
%
|
||
Revenue | 919 919 |
10%
10%
|
|
Gross Profit | 142 142 |
13%
13%
|
|
EBITDA | 68 68 |
78%
78%
|
EBIT (Operating Income) EBIT | -8.50 -8.50 |
293%
293%
|
Net Profit | -131 -131 |
31%
31%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company was founded in 1976 and is headquartered in Antony, France.
Head office | France |
CEO | Mr. Seignolle |
Employees | 3,329 |
Founded | 2020 |
Website | www.euroapi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.